Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting Conditions

NCT05477810 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Treatment A (investigational drug) followed by Treatment B (reference drug)
DRUG: Treatment B (reference drug) followed by Treatment A (investigational drug)

Sponsor

University Children's Hospital Basel

Collaborators

[object Object]
[object Object]